Anna Sjogren

Director Clinical Development at Rare Thyroid Therapeutics - Stockholm, Stockholm County, Sweden

Anna Sjogren's Colleagues at Rare Thyroid Therapeutics
Anna Sjogren's Contact Details
HQ
Location
Stockholm,Stockholm County,Sweden
Company
Rare Thyroid Therapeutics
Anna Sjogren's Company Details
Rare Thyroid Therapeutics logo, Rare Thyroid Therapeutics contact details

Rare Thyroid Therapeutics

Stockholm, Stockholm County, Sweden • 3 Employees
Pharmaceuticals

Rare Thyroid Therapeutics is a privately held pharmaceutical company, developing therapies for rare and neglected thyroid hormone disorders. Our lead product candidate Emcitate® is under development for the treatment of MCT8 deficiency, also called Allan-Herndon-Dudley Syndrome, a rare inborn X-linked disorder caused by a dysfunctional thyroid hormone transporter.

Details about Rare Thyroid Therapeutics
Frequently Asked Questions about Anna Sjogren
Anna Sjogren currently works for Rare Thyroid Therapeutics.
Anna Sjogren's role at Rare Thyroid Therapeutics is Director Clinical Development.
Anna Sjogren's email address is ***@egetis.com. To view Anna Sjogren's full email address, please signup to ConnectPlex.
Anna Sjogren works in the Pharmaceuticals industry.
Anna Sjogren's colleagues at Rare Thyroid Therapeutics are and others.
Anna Sjogren's phone number is
See more information about Anna Sjogren